F. E. SOROKO - Concepedia

Author

F. E. SOROKO

Burroughs Wellcome Fund

Also Known As

F E SOROKO, F E Soroko, F Soroko, F. E. SOROKO, F. E. Soroko, F. Soroko, FE Soroko, Francis E. Soroko

Publications

694

Citations

H-Index

Concepts

All Affiliations

Burroughs Wellcome Fund Research Triangle Park Foundation Wellcome Trust

About

F. E. SOROKO is an author at Burroughs Wellcome Fund specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	490
2	Social Sciences	5	5	203
3	Natural Sciences	2	2	143
4	Engineering	1	1	12
5	Public Health	1	1	49

F. E. SOROKO

Publications

675

Citations

H-Index

Page 1

	Year	Citations
1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: Synthesis and Anticonvulsant Activity James L. Kelley, Cecilia S. Koble, Richard G. Davis, Journal of Medicinal Chemistry	1995	122
Bupropion hydrochloride ((±) α-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent F. E. SOROKO, Nariman B. Mehta, R.A. Maxwell, Journal of Pharmacy and Pharmacology Pharmaceutical SciencePsychotropic MedicationPsychopharmacologyOrganic ChemistryPharmacotherapy	1977	119
The effects of apomorphine, (+)-amphetamine and l-dopa on maximal electroshock convulsions—a comparative study in the rat and mouse Gerald M. McKenzie, F. E. SOROKO Journal of Pharmacy and Pharmacology Synaptic TransmissionNeurotransmitterNeuromodulation TherapiesExperimental PharmacologySocial Sciences	1972	67
BW234U,(<i>cis</i>-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent R M Ferris, M. Harfenist, Gerald M. McKenzie, Journal of Pharmacy and Pharmacology Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryPharmaceutical SciencePsychiatry	1982	53
ENZYME INDUCTION AND INHIBITION IN STUDIES ON THE PHARMACOLOGICAL ACTIONS OF ACETOPHENETIDIN A. H. Conney, M. Sansur, F. E. SOROKO, Journal of Pharmacology and Experimental Therapeutics	1966	51
The effect of cyproheptadine on food consumption in the fasted rat. Mark G. Baxter, A A Miller, F. E. SOROKO PubMed Animal PhysiologyNutritionMedicinePhysiologyExperimental Pharmacology	1970	49
On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine Fridolin Sulser, F. E. SOROKO Psychopharmacology NeurophysiologyMedicinePsychopharmacologyBrain Norepinephrine ReleaseNeuropharmacology	1965	43
A Novel Inhibitor of Gamma‐Aminobutyrate Aminotransferase with Anorectic Activity Helen L. White, J. L. Howard, Barrett R. Cooper, Journal of Neurochemistry NeurotransmitterAnorectic ActivityPharmacotherapyExperimental PharmacologySocial Sciences	1982	43
Pharmacological Properties of 403U76, a New Chemical Class of 5-Hydroxytryptamine- and Noradrenaline-reuptake Inhibitor R M Ferris, Lawrence E. Brieaddy, Nariman B. Mehta, Journal of Pharmacy and Pharmacology Noradenaline ReuptakePsychotropic MedicationPharmacotherapyExperimental PharmacologySocial Sciences	1995	38
8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity. James L. Kelley, J. A. LINN, Donald Bankston, Journal of Medicinal Chemistry Medicinal ChemistryAntiparasitic AgentMedicinePurine RingPharmacological Agent	1995	30

Page 1